Eur Rev Med Pharmacol Sci 2022; 26 (11): 3799-3799
DOI: 10.26355/eurrev_202206_28946

MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7

Y. Xiao, S.-J. Zhang, X. Yan, C. Wu, Q.-W. Liu, H.-X. Dong, L.-J. Wang, Y. Hu

Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing, China


The article “MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7, by Y. Xiao, S.-J. Zhang, X. Yan, C. Wu, Q.-W. Liu, H.-X. Dong, L.-J. Wang, Y. Hu, published in Eur Rev Med Pharmacol Sci 2021; 25 (18): 5625-5635–DOI: 10.26355/eurrev_202109_26782–PMID: 34604955” has been retracted by the authors as they state that some data cannot be repeated by further experiments.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/26782

Free PDF Download

To cite this article

Y. Xiao, S.-J. Zhang, X. Yan, C. Wu, Q.-W. Liu, H.-X. Dong, L.-J. Wang, Y. Hu
MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 11
Pages: 3799-3799
DOI: 10.26355/eurrev_202206_28946